Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Van Niekerk shines in Ostrava and breaks 300 m world record
2017-06-29

Description: Van Niekerk shines in Ostrava  Tags: Van Niekerk shines in Ostrava

Wayde van Niekerk is in great form leading up to the
World Championships in London in August.
Photo: Khothatso Mokone

Usain Bolt believes Wayde van Niekerk could well be his successor. Bolt, who has won eight Olympic and 11 world gold medals in his career, doesn’t doubt that the Kovsie athlete could take over the reins as an athletic superstar.

This after Van Niekerk broke another world record by Michael Johnson – 30.85 seconds in the 300 m which Johnson set in Pretoria in 2000 – at the IAAF Golden Spike meeting in Ostrava, Czech Republic, on 28 June 2017. He took the honours in the 300 m in a time of 30.81 seconds. In 2016, Van Niekerk also improved on Johnson’s 400 m world record (43.18 s) with a time of 43.03 s at the Rio Olympics.

Unique honour over four distances
Because the 300 m event is not run very often, the record will be regarded as the world’s best by the IAAF. According to the IAAF, the 24-year-old Van Niekerk is now also the first man to run a sub-10 for the 100 m, sub-20 for 200 m, sub-31 for 300 m, and sub-44 for 400 m.

The legendary Bolt, who is in his final season, admitted that Van Niekerk could take over from him. “I think he really wants to be a sprinter, because he's set a personal best in the 100 m this year,” he said to AFP.

“He's shown that he's ready for the challenge. He's really down to earth, he's really humble, he's a great person. He listens and wants to be good, and if he continues like this he'll take over track and field."

Great run prior to Czech Republic
The 300 m world record follows after Van Niekerk also ran a personal best time of 9.94 in the 100 m in Velenje, Slovenia, on 20 June 2017. The 400 m world record-holder also became the South African record-holder in the 200 m again when ran a 19.84 in the 200 m at the Racers Grand Prix in Kingston, Jamaica, on 11 June 2017.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept